e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
Healthcare organisation and appropriateness in lung disorders
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Quality indicators for management of community-acquired pneumonia
hiroaki kanemura (tokyo, Japan), Hiroaki Kanemura, Naoki Nishimura, Hiroshi Nakaoka, Takeshi Kimura, Naohiko Chounabayashi
Source:
International Congress 2015 – Healthcare organisation and appropriateness in lung disorders
Session:
Healthcare organisation and appropriateness in lung disorders
Session type:
Thematic Poster Session
Number:
707
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
hiroaki kanemura (tokyo, Japan), Hiroaki Kanemura, Naoki Nishimura, Hiroshi Nakaoka, Takeshi Kimura, Naohiko Chounabayashi. Quality indicators for management of community-acquired pneumonia. Eur Respir J 2015; 46: Suppl. 59, 707
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Comparison of the predictive performance of severity assessment tools in community-acquired or health care-associated pneumonia
Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia
Year: 2013
Outcomes characteristics in healthcare-associated pneumonia
Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia
Year: 2018
Physical deterioration during hospitalization in patients with community-acquired pneumonia
Source: International Congress 2015 – Effects of rehabilitation, exercise, physical activity, hospitalisation and surgery on different conditions
Year: 2015
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
Source: Guideline 2017
Year: 2017
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
Source: Eur Respir J, 50 (3) 1700582; 10.1183/13993003.00582-2017
Year: 2017
Healthcare-associated pneumonia: Comparative characteristics with community-acquired pneumonia
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015
Clinical characteristics of extremely elderly patients with community-acquired and healthcare-associated pneumonia in Japan
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013
Challenges in the management of hospital-acquired pneumonia including ventilator-associated pneumonia
Source: ERS Course 2018 - Respiratory Infections
Year: 2018
Bacteraemia in outpatient with community-acquired pneumonia
Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants
Year: 2015
Severity assessment of healthcare-associated pneumonia and pneumonia in immunosuppression
Source: Eur Respir J 2012; 40: 1201-1210
Year: 2012
Impact of aspiration pneumonia in community-acquired pneumonia and healthcare-associated pneumonia
Source: Annual Congress 2012 - CT findings: educational posters
Year: 2012
Influence of comorbidities on pneumococcal community-acquired pneumonia
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013
Health care-associated pneumonia and community-acquired pneumonia: A single-center experience
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015
Risk factors of paediatric community-acquired pneumonia
Source: Eur Respir J 2011; 37: 724-725
Year: 2011
The neutrophil/lymphocyte ratio in predicting outcome for hospitalized patients with community-acquired pneumonia
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014
Predictors of treatment failure in patients with bacteremic pneumococcal community-acquired pneumonia
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013
Biomarkers and clinical stability in community-acquired pneumonia
Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers
Year: 2009
Burden of community-acquired pneumonia in Italian general practice
Source: Eur Respir J 2013; 42: 1739-1742
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept